Low-Frequency Transcranial Magnetic Stimulation (LF-TMS) in Treating Depression in Patients With Impaired Cognitive...

Area of Science:

• Neuroscience
• Psychiatry
• Cognitive Science

Background:

• Standard depression treatments are less effective for individuals with cognitive impairments.
• Transcranial magnetic stimulation (TMS) is FDA-approved for major depressive disorder.
• Limited research exists on TMS for depression in cognitively impaired populations.

Purpose of the Study:

• To assess the efficacy of low-frequency TMS (LF-TMS) for depressive symptoms in individuals with impaired cognitive functioning.
• To investigate if LF-TMS improves neurocognitive function independently of depressive symptom reduction.

Main Methods:

• Utilized data from 53 participants treated with LF-TMS.
• Assessed depressive symptoms using Beck Depression Inventory II (BDI-II).
• Evaluated neurocognitive function with CNS Vital Signs (CNS-VS) and analyzed data using hierarchical linear modeling.

Main Results:

• LF-TMS significantly reduced depressive symptoms in both impaired and average cognitive functioning groups.
• A significant group-by-time interaction indicated differential treatment effects.
• LF-TMS improved three neurocognitive domains, though reliability requires further investigation.

Conclusions:

• LF-TMS demonstrates efficacy in treating depressive symptoms in individuals with cognitive impairments.
• Findings support LF-TMS's potential to enhance neurocognitive functioning beyond its effects on depression.